Genzyme

Europe and US Diverge On Two New Drugs

Europe and US Diverge On Two New Drugs

Forbes

EMA rejects Genzyme re-examination request for Kynamro

EMA rejects Genzyme re-examination request for Kynamro

Yahoo/Fly on the Wall

Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target

Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target

Motley Fool

Isis: FDA Approval Of Kynamro Promises A Bright Future For Company

Isis: FDA Approval Of Kynamro Promises A Bright Future For Company

Seeking Alpha

FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia Comment Now Follow Comments

FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

Forbes

Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO

Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO

Yahoo/Fly on the Wall

Genzyme resolves shortage of cancer drug Thyrogen

Genzyme resolves shortage of cancer drug Thyrogen

Fierce Pharma

Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia

Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia

Yahoo

Isis Pharma/Genzyme FDA Panel Live Blog

Isis Pharma/Genzyme FDA Panel Live Blog

TheStreet.com

Sanofi Aims to Add Second-Generation Lemtrada to Pipeline

Sanofi Aims to Add Second-Generation Lemtrada to Pipeline

Bloomberg